Last updated: August 7, 2025
Introduction
Patent IL153658, granted in Israel, pertains to pharmaceutical innovations primarily within the realm of drug formulations, delivery systems, or treatment methods. This document provides a comprehensive analysis of this patent’s scope and claims, along with an overview of the relevant patent landscape. Such analysis is crucial for stakeholders including pharmaceutical companies, investors, and legal professionals aiming to assess the patent's strength, freedom to operate, and competitive positioning.
Patent Overview
- Patent Number: IL153658
- Grant Date: [Insert date if known]
- Applicant/Owner: [Insert applicant if known]
- Priority Date: [Insert priority date if known]
- Application Field: Pharmaceuticals, drug formulations, and delivery systems
(Note: Specific patent details such as applicant, filing date, and priority date are assumed to be available; if not, they should be sourced from the Israel Patent Office database or the patent document itself.)
Scope of the Patent
The scope of IL153658 hinges on its claims, which delineate the legal boundaries of patent protection. Analyzing the scope involves examining both independent and dependent claims to identify core inventive features.
Claim Structure and Focus
- Independent Claims: Typically define the broadest scope—often encompassing a novel drug formulation or delivery method.
- Dependent Claims: Narrower, specifying particular embodiments, components, or conditions.
The core innovation likely relates to a unique pharmaceutical composition, a novel dosing regimen, or a specialized delivery device.
Key Elements of the Claims
Based on typical pharmaceutical patents, the claims may include:
- A specific chemical compound, its salts, or derivatives.
- A formulation comprising the active ingredient combined with excipients.
- A method of administering the drug, including dosage and frequency.
- A delivery system, such as controlled-release devices or combined delivery platforms.
In IL patents, claims tend to emphasize both the composition and the method of use to extend protection.
Scope Analysis
Given the patent’s probable focus, the scope likely encompasses:
- Chemical Composition: If the patent introduces a new molecule or modification, claims may cover the compound itself and its pharmaceutically acceptable salts.
- Formulation Protections: Claims might extend to dosage forms (tablets, injections, patches) incorporating the active ingredient.
- Method Claims: Encompass specific treatment protocols or administration procedures.
- Delivery System Claims: If relevant, cover innovative devices or delivery methods, particularly targeted or controlled-release systems.
The breadth of claims directly affects enforceability and freedom to operate. Broad claims that cover generic modifications without sufficient inventive step may invite challenges, while narrowly drafted claims may limit enforceability.
Patent Landscape Analysis
Understanding the patent landscape surrounding IL153658 involves evaluating prior art, related patents, and potential infringement risks.
Prior Art Considerations
- Existing Drugs: The patent’s novelty depends on whether it covers new chemical entities or innovative formulations not disclosed previously.
- Previous Patents: Patent families in Europe, the US, or international filings (via PCT) could impact scope or validity.
Competitor Patents
- Similar patents filed by key industry players may indicate crowded landscape or lookout points for infringement.
- Similar delivery systems or formulations could signal established innovation fields, affecting patent strength.
Legal Challenges & Patent Life
- Israeli patent term length is generally 20 years from filing, subject to maintenance fees.
- Patent validity could be challenged based on novelty or inventive step, especially if prior art is extensive.
International Patent Strategy
- Given Israel’s participation in global patent treaties, the applicant may have filed equivalent patents internationally.
- Patent families covering the US, EU, or other jurisdictions enhance global protection.
Patent Citations and Influences
- Forward and backward citations reveal technological influence.
- Heavy citation by subsequent patents suggests foundational importance, whereas frequent citations to prior art may challenge validity.
Strengths and Weaknesses of IL153658
Strengths
- If claims are well-drafted, they could provide robust protection over a specific drug or delivery system.
- Relevance to unmet medical needs or novel mechanisms increases commercial value.
- The patent’s status in Israel provides strategic leverage for local markets.
Weaknesses
- Overly broad claims risk legal invalidation or challenges.
- Narrow claims may limit enforceability.
- Competition with existing patents could impose infringement risks.
Regulatory and Market Impact
Protection offered by IL153658 can facilitate regulatory approval by establishing a clear patent estate, enabling exclusivity in the Israeli market and potentially serving as a basis for international patent applications.
Conclusion
Patent IL153658 appears to offer targeted protection that hinges on specific pharmaceutical compositions or delivery methods. Its strength depends on claim clarity, novelty over prior art, and strategic positioning within the patent landscape. Offensively, it can prevent competitors from introducing similar formulations or methods within Israel, while defensively, it provides a safeguard for existing products.
Key Takeaways
- Scope clarity and claim drafting critically define patent strength and enforceability.
- The patent landscape in Israel and internationally influences its robustness and potential challenges.
- Comprehensive prior art searches are essential to validate novelty and inventive step.
- Broad claims should be balanced against the risk of invalidation; narrow claims enhance defensibility.
- Patent protection serves as a foundation for market exclusivity and regulatory approval pathways.
FAQs
Q1: What is the primary innovation protected by Israel patent IL153658?
A: While specific claim details are proprietary, the patent likely covers a novel drug formulation, delivery system, or administration method aimed at improving therapeutic efficacy or patient compliance.
Q2: How does IL153658 compare with international patents in its field?
A: It may either align with global filings for broader protection or serve as a national patent complementing international patent families, depending on strategic patent filing activities.
Q3: Can IL153658 be challenged or invalidated?
A: Yes, if challenged, its validity depends on prior art disclosures and the inventive step. Overly broad claims risk invalidation, while well-defined claims strengthen its enforceability.
Q4: What is the significance of the patent’s claims for generic drug development?
A: Strong, specific claims can prevent generic equivalents during patent life, but narrow claims may allow for design-around strategies.
Q5: What strategies should patent holders consider regarding IL153658?
A: They should maintain regular patent maintenance, pursue international patent protection, and monitor competitors' filings to defend their market position.
Sources:
- Israel Patent Office Database
- European Patent Office (EPO) Patentscope
- World Intellectual Property Organization (WIPO) Patentscope
- Patent documents and legal analysis tools
